Off the Scales: The Inside Story of Ozempic and the Race to Cure Obesity
Premium Members save an extra 10% and all Members collect stamps to save with Rewards. 10 stamps = $5.
Shortlisted for the Financial Times and Standard Chartered Business Book of the Year Award 2026!
The inside story of the creation of Ozempic and its revolutionary impact on public health.
A “cure” for obesity has long been the holy grail for the pharmaceutical industry, one that seemed unattainable until recent breakthroughs in type 2 diabetes research led to the development of Ozempic, a weight loss medication that activates a hormone in the stomach called GLP-1, making people feel fuller fo...






















